Eosinophils Target Therapy for Severe Asthma: Critical Points
Asthma is a chronic and heterogeneous disease, which is defined as severe disease whenever it requires treatment with a high dose of inhaled corticosteroids plus a second controller and/or systemic corticosteroids to prevent it from becoming ‘‘uncontrolled’’ or if it remains ‘‘uncontrolled’’ despite...
Main Authors: | L. Brussino, E. Heffler, C. Bucca, S. Nicola, G. Rolla |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/7582057 |
Similar Items
-
Is it severe asthma or asthma with severe comorbidities?
by: Brussino L, et al.
Published: (2017-11-01) -
Targeting eosinophils: severe asthma and beyond
by: Marco, et al.
Published: (2019-07-01) -
Severe Eosinophilic Asthma
by: Agamemnon Bakakos, et al.
Published: (2019-09-01) -
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study
by: Paolo Solidoro, et al.
Published: (2019-04-01) -
New therapy options for patients with eosinophilic type of severe bronchial asthma
by: G. L. Ignatova, et al.
Published: (2020-01-01)